ClearPoint Neuro, Inc. (CLPT) NASDAQ
12.37
-0.27(-2.14%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
ClearPoint Neuro, Inc.
Address
120 S. Sierra Avenue
Solana Beach, CA 92075
United States of America (the)
Phone
888 287 9109
Sector
Healthcare
Industry
Medical - Devices
Employees
115
First IPO Date
May 22, 2012
Key Executives
| Name | Title | Pay | Year Born |
| Joseph Michael Burnett | President, Chief Executive Officer & Director | 1.01M | 1977 |
| Robert C. Korn | Senior Vice President of Sales & Business Development | 305,123 | 1965 |
| Jeremy Stigall | Chief Business Officer | 522,809 | 1984 |
| Danilo D'Alessandro | Chief Financial Officer | 554,360 | 1985 |
| Megan Faulkenberry | Senior Vice President of Quality | 0 | N/A |
| Mazin Sabra | Chief Operating Officer | 0 | 1980 |
| Ellisa Cholapranee | General Counsel & Secretary | 0 | N/A |
| Mary McNamara-Cullinane | Senior Vice President of Regulatory Affairs | 0 | N/A |
| Paul S. Larson FAANS | Chief Medical Officer | 0 | N/A |
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.